BME 301 Lecture Nine.

Slides:



Advertisements
Similar presentations
BIOE 301 Lecture Nine. Summary of Lecture 8 Pathogens: Bacteria and Virus Levels of Immunity: Barriers  First line of defense Innate  Inflammation Phagocytes.
Advertisements

Microbiology B.E Pruitt & Jane J. Stein AN INTRODUCTION TORTORA FUNKE CASE Chapter 18 Practical Applications of Immunology.
Vaccines
Vaccine development: from idea to product Veronica Leautaud, Ph.D. rice.edu Keck Hall 224 / 232-lab Lecture 9 BIOE 301-Bioengineering and World Health.
Vaccination. NATURALLY ACQUIRED IMMUNITY Active: Acquired through contact with microorganisms (infection). Provides long term protection. Passive: Antibodies.
Preventing Communicable Diseases
1 Latin for “poison” A virus is a particle that can only be seen with an electron microscope.
The Immune System A complex group of defenses found in the body that fight against harmful substances and pathogens Pathogen: infectious agent (or germ)
What They Are How They Work
A vaccine is biological preparation that improves immunity to a particular disease, a vaccine typically contains a disease causing micro-organisms often.
Vaccination. Vocabulary Check Vaccination: conferring immunity to a disease by injecting an antigen (of attenuated microorganisms or inactivated component)
BIOE 301 Lecture Nine Amit Mistry Feb 8, BIOE 301 – Lecture 9 WARM-UP What type of immune defense is involved in each of the following: A flu virus.
Immune system dynamics. Figure 17.1 Antibody- antigen binding Figure 17.1 Antigens (Ag) Protein or polysaccharide Can be attached or free from cell Antibodies.
BIOE 301 Lecture Nine. Engineering Design Method Designing a product to meet a practical goal in the presence of constraints Six design steps: 1. Identify.
Vaccine development: from idea to product Lecture 9 Biomedical Engineering for Global Health.
Note Sheet 16 - Viruses Swine (H1N1) Flu Viruses.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
Vaccine development: from idea to product Lecture 9 Biomedical Engineering for Global Health.
BME 301 Lecture Eight. Review of Lecture 7 Science “Science is the human activity of seeking natural explanations for what we observe in the world around.
Protection against Disease
PRESENTED BY : 1. TAHSIN TASNIM ATASHI 2. SAMIHA ASHREEN 3. ZAREEN NAWAR.
I. Disease Caused by Disease – a condition of ill health; one or more body parts are not functioning properly. I. Disease.
Chapter 17 Applications of Immune Responses. A Glimpse in History Chinese writings from the Sung Dynasty (AD ) indicate a process called variolation,
How vaccines work. Prevention of diseases. Your Immune System (lymphatic system) It is always better to prevent a disease than to treat it after it occurs.
Viruses, Bacteria & Protists…oh MY! Disease causing agents that activate the immune system.
Vaccination. immunity adaptive natural active passive artificial active passive innate.
NEW TECHNOLOGIES IN VACCINES. Vaccination – is the introduction into the body of a weakened, killed or piece of a disease-causing agent to prevent disease.
Viruses: Beneficial, Infections, and Vaccines BY: OWEN RHYDDERCH, MORGAN TREVINO, AND EVAN CASEY.
Viruses :Tiny Biological Particles Size video.
Vaccines Dr. Sarah I. Bukhari 324 PHT PhD in Clinical Microbiology
Viruses :Tiny Biological Particles Size video.
Chapter 16 Immunizations and Immunity. Amazing Fact “An estimated 2.1 million people around the world died in 2002 of diseases preventable by widely used.
Immune System Part 1: Infectious Disease
Smallpox Smallpox was one of the most devastating diseases the world has ever known. It killed millions of people every year. Few people reached adulthood.
Viral pathogens and Vaccination
Vaccine Education Module: Vaccines Updated: February 2015
Viruses…. Are they alive?
IMMUNIZATION د. رائد كريم العكيلي
Manipulation of the Immune Response Vaccination
Unit 4 - Immunology and Public Health
Outline Immunity Artificial active immunization (vaccination)
VIRUSES B 4.C Compare the structures of viruses to cells, describe viral reproduction, and describe the role of diseases such as human immunodeficiency.
Vaccines stimulate immunity
Basic Concepts in Immunity
Immunity and Immunizations
Viral pathogens and Vaccination
Specific Immunity and Immunization
Even 2,500 Years Ago, People Knew Immunity Worked.
History of Vaccines Variolation: inoculation of smallpox into skin (eighteenth century) Vaccination: Inoculation of cowpox virus into skin (Jenner) Inoculation.
Making Vaccines.
Vaccination Vaccination is the second most effective
Vaccine development: from idea to product
Viruses: Beneficial, Infectious, and Vaccines
Preventing Communicable Diseases
Viruses Biology I.
Vaccines.
BIOE 301 Lecture Eight.
Viruses Doesn’t belong to any kingdom -It’s not a plant or an animal.
The Microscopic menace
Say Hello to My Little Friend
Ch. 18 Viruses and Bacteria
Vaccine development: from idea to product
New Technologies in Vaccines
Immunization/Vaccination
A brief discussion on passive and active (esp., vaccines) immunity
How Vaccines work.
Key Area 3.7: Immunisation
Vaccinations.
Presentation transcript:

BME 301 Lecture Nine

Summary of Lecture 8 Pathogens: Bacteria and Virus Levels of Immunity: Barriers  First line of defense Innate  Inflammation Phagocytes Complement Adaptive  Immunologic memory Antibody mediated immunity Cell mediated immunity  Pathogens within cells Diversity to recognize 100 million antigens

Class Activity 2 The Immune System

Q3: How can technology solve health care problems? CS1: Prevention of infectious disease

Outline Pathogens: How They Cause Disease The Immune System: How We Fight Disease How Vaccines Work The Power of Vaccines: Childhood Illnesses Designing a New Vaccine: HIV/AIDS

Roadmap of CS 1 Science Engineering Vaccines: From idea to product Organisms that cause disease Immunity Engineering How to make a vaccine Vaccines: From idea to product Societal Impact Health and economics Ethics of clinical trials Developed world/Developing world

Viruses Three basic problems each must solve How to reproduce inside a human cell How to spread from one person to another Inhale Eat During birth Intimate physical contact How to evade the immune system

Influenza Viral Reproduction - 1 Must get inside human cell to use cell’s biosynthetic machinery Influenza virus binds to cell receptor Induces receptor mediated endocytosis

Influenza Viral Reproduction - 2 pH slowly reduced in endosome, virus releases its single stranded RNA and polymerase proteins RNA segments and polymerase proteins enter nucleus of infected cell Cell begins to make many copies of the viral RNA and viral coat proteins

Influenza Viral Reproduction - 3 New viral particles exit nucleus and bud from cell Viral polymerase proteins don’t proofread reproduction Nearly every virus produced in an influenza infected cell is a mutant

Influenza Viral Spread Infected person sneezes or coughs Micro-droplets containing viral particles inhaled by another person Penetrates epithelial cells lining respiratory tract Influenza kills cells that it infects Can only cause acute infections Cannot establish latent or chronic infections How does it evade immune extinction? Antigenic drift Caused by point mutations Yearly vaccination http://www.bme.utexas.edu/faculty/richards-kortum/BME301/thisweek/archives.htm http://students.washington.edu/grant/random/sneeze.jpg

Influenza How does the virus cause symptoms? Cells of respiratory tract are killed by virus or immune system Resulting inflammation triggers cough reflex to clear airways of foreign invaders Influenza infection results in production of large quantities of interferon Fever Muscle aches Headaches Fatigue MMR Weekly

Genetic Shift and Flu Pandemics Animals co-infected by different strains of virus Viral gene segments randomly reassociate Reassortment of virus segments from birds, pigs, etc is source of new strains that infect humans How does this happen? Virus shed in bird feces, gets into pigs' drinking water Humans handle and/or cough on the pig New virus - segments from humans, birds & pigs China: Breeding ground for new influenzas strains Proximity of humans, pigs, and ducks in China Asian flu, Hong Kong flu, etc. http://www.cdc.gov/flu/avian/facts.htm

Vaccines How Are They Made?

Vaccination Vaccination: Goal of vaccination: Practice of artificially inducing immunity Goal of vaccination: Make memory T helper cells, memory killer T cells, and memory B cells that will protect the vaccinated person against future exposure to pathogen Want the vaccine to have: Maximum realism Minimum danger

What is needed to make memory cells? Memory B Cells & Memory Helper T Cells: B and T cell receptors must see virus or viral debris Memory Killer T Cells: Antigen Presenting Cells must be infected with virus

Types of Vaccines Non-infectious vaccines DTaP Pneumococcus Live, attenuated bacterial or viral vaccines Chicken Pox Carrier Vaccines DNA Vaccines

Non-infectious vaccines Killed bacterial or inactivated viral vaccines Treat pathogen with chemicals (like formaldehyde) Impossible to guarantee that you have killed all the pathogen Salk (inactivated) Polio vaccine, rabies vaccine Subunit vaccines Use part of pathogen OR Use genetic engineering to manufacture pathogen protein No danger of infection Hepatitis A & B, Haemophilus influenza type b, pneumonoccocal conjugate vaccines Toxoid vaccines Bacterial toxins that have been made harmless Diphtheria, tetanus and pertussis vaccines This approach will make memory B cells and memory helper T cells, but NOT memory killer T cells Booster vaccines usually required

Live, attenuated vaccines Grow pathogen in host cells Produces mutations which: Weaken pathogen so it cannot produce disease in healthy people Pathogen still produces strong immune response that protects against future infection Sabin Polio vaccine (oral Polio) Measles, mumps, rubella, varicella vaccines This approach makes memory B cells, memory helper T cells, AND memory killer T cells Usually provide life-long immunity Can produce disease in immuno-compromised host

Cell Culture: Live, Attenuated Vaccine Grow cells: Removed from tissue In vitro (in glass) By supplying nutrients and other factors Specific O2 and CO2 (pH level) Glucose, ions Serum from blood: proteins

Passaging Cells Dissection/ Primary Organ Breakdown… Cell Line Add media for growth Incubate Divide -> transferred Secondary Cell Line

Carrier Vaccines Use virus or bacterium that does not cause disease to carry viral genes to APCs e.g. vaccinia for Smallpox vaccine http://www.bme.utexas.edu/faculty/richards-kortum/BME301/thisweek/thisweek.htm This approach makes memory B cells, memory helper T cells, AND memory killer T cells Does not pose danger of real infection Immuno-compromised individuals can get infection from carrier Carrier must be one that individuals are not already immune to Cannot make booster vaccines with carrier (must use different carrier for booster)

DNA Vaccines DNA injections can produce memory B cells and memory T killer cells Reasons are not fully understood Make a DNA vaccine from a few viral genes No danger that it would cause infection

Types of Vaccines Non-infectious vaccines No danger of infection Does not stimulate cell mediated immunity Usually need booster vaccines Live, attenuated bacterial or viral vaccines Makes memory B cells, memory helper T cells, AND memory killer T cells Usually provides life-long immunity Can produce disease in immuno-compromised host Carrier Vaccines Does not pose danger of real infection Immuno-compromised individuals can get infection from carrier DNA Vaccines

Effectiveness of Vaccines Vaccination Effectiveness About 1-2 of every 20 people immunized will not have an adequate immune response to a vaccine Herd Immunity Vaccinated people have antibodies against a pathogen They are much less likely to transmit that germ to other people Even people that have not been vaccinated are protected About 95% of community must be vaccinated to achieve herd immunity Does not provide protection against non-contagious diseases – eg tetanus

Vaccines How Are They Tested?

Vaccine Testing Laboratory testing Animal Model Animal must be susceptible to infection by agent against which vaccine is directed Animal should develop same symptoms as humans

Vaccine Testing Human Trials Phase I NPR Story – Ebola Vaccine Trials Small number of volunteers (20-100) Usually healthy adults Last few months Determine vaccine dosages that produce levels of memory B or T cells that are likely to be protective Evaluate side effects at these dosages FDA must approve the vaccine as an Investigational New Drug (IND) NPR Story – Ebola Vaccine Trials http://www.npr.org/rundowns/segment.php?wfId=1513230

Vaccine Testing Human Trials Phase II Larger number of volunteers (several hundred) Last few months to few years Controlled study, with some volunteers receiving: Vaccine Placebo (or existing vaccine) Endpoints: Effectiveness, safety

Vaccine Testing Human Trials Phase III Large number of volunteers (several hundred to several thousand) Last years Controlled double blind study, with some volunteers receiving: Vaccine Placebo (or existing vaccine) Neither patients nor physicians know which was given

Vaccine Testing Role of the FDA: Post-licensure surveillance Licensure by FDA required before a company can market the vaccine (about a decade) Each batch of vaccine must be tested for safety, potency, purity and sample lot must be sent to FDA Post-licensure surveillance Doctors must report adverse reactions after vaccination to FDA and CDC Vaccine Adverse Events Reporting System (VAERS) As many as 12,000 reports per year, 2,000 serious Most are unrelated to the vaccine

Vaccine Testing Recommendations by health departments and expert physician groups When should vaccine be used Who should receive it Weigh: risks and benefits of the vaccine, costs of vaccination Legislation: States determine which vaccines are required by law All 50 states have school immunization laws Can be exempted based on: Medical reasons (50 states) Religious reasons (48 states) Philosophical reasons (15 states)

Vaccine Schedule By age two: 20 shots!! Single visit: Up to 5 shots!! Birth Hepatitis B 2 Months DTap #1 Polio #1 Hib #1 Hepatits B #2 Pneumococcus #1 4 months DTaP #2 Polio #2 Hib #2 Pneumococcus #2 6 months DTaP #3 Hib #3 Pneumococcus #3 12 months MMR #1 Varicella 15 months Hib #4 Polio #3 Hepatitis B #3 Pneumococcus #4 DTap #4 4-6 years MMR #2 Polio #4 DTaP #5 11-12 years Tetanus, Diphtheria By age two: 20 shots!! Single visit: Up to 5 shots!! http://www.christianpoint.org/inspiration/images/crying_baby.jpg

Recommended Vaccine Schedule

History of the Rotavirus Vaccine Withdrawn from the market after post-licensure surveillance indicated small number of adverse effects

Vaccines Are They Effective?

History of Vaccination Seventh Century Indian Buddhists drank snake venom to induce immunity (through toxoid effect) Second millennium Variolation against smallpox Central Asia, China, Turkey 1721 Variolation against smallpox moves from Turkey to England

History of Vaccination History: 1798 - Edward Jenner noted: Smallpox and Cowpox: Milkmaids frequently contracted cowpox which caused lesions similar to that smallpox Milkmaids who had cowpox almost never got smallpox Jenner’s (unethical) experiment: Collected pus from cowpox sores Injected cowpox pus into boy named James Phipps Then injected Phipps with pus from smallpox sores Phipps did not contract smallpox First to introduce large scale, systematic immunization against smallpox

History of Vaccination 1885: Attenuation Louis Pasteur - first vaccine against rabies Early 1900s: Toxoids Diphtheria, tetanus 1936 Influenza 1950s: Tissue Culture Polio (Nobel Prize for Enders, Robbins, Weller) 1960s: Measles, Mumps, Rubella

Effects of Vaccination in US Disease Max # of Cases # Cases in 2000 % D Diphtheria 206,929 (1921) 2 -99.99 Measles 894,134 (1941) 63 Mumps 152,209 (1968) 315 -99.80 Pertussis 265,269 (1952) 6,755 -97.73 Polio 21,269 (1952) -100 Rubella 57,686 (1969) 152 -99.84 Tetanus 1,560 (1923) 26 -98.44 HiB ~20,000 (1984) 1,212 - 93.14 Hep B 26,611 (1985) 6,646 -75.03

Effects of Vaccination Smallpox First human disease eradicated from the face of the earth by a global immunization campaign 1974 Only 5% of the world’s children received 6 vaccines recommended by WHO 1994 >80% of the world’s children receive basic vaccines Each year: 3 million lives saved

Smallpox One of world’s deadliest diseases Elimination of smallpox Vaccine available in early 1800s Difficult to keep vaccine viable enough to deliver in developing world Elimination of smallpox 1950: stable, freeze dried vaccine 1950: Goal  Eradicate smallpox from western hemisphere 1967: Goal achieved except for Brazil 1959: Goal  Eradicate smallpox from globe Little progress made until 1967 when resources dedicated, 10-15 million cases per year at this time Strategies: Vaccinate 80% of population Surveillance and containment of outbreaks May 8, 1980: world certified as smallpox free

Childhood Immunization 1977: Goal to immunize at least 80% of world’s children against six antigens by 1990

rtsp://audio.npr.org/me/20021120.me.10.smil

Vaccines What is Still Needed?

What Vaccines are needed? The big three: HIV Malaria Tuberculosis

Summary of Lecture 9 How do vaccines work? How are vaccines made? Stimulate immunity without causing disease How are vaccines made? Non-infectious vaccines Live, attenuated bacterial or viral vaccines Carrier Vaccines DNA Vaccines How are vaccines tested? Lab/Animal testing Phase I-III human testing Post-licensure surveillance Impact of vaccines

Assignments Due Next Time Two reading assignments: WTIND - p. 147, 172, 182-185, 311-315 CPS - 767-782 WA5 (Vaccines)